The Maine Wire: Congress Should Preserve Public Quality Standards for Biologic Drugs Posted on August 28, 2019 by Liam Sigaud Congress should preserve public quality standards for biologic drugs Further ReadingCoalition Letter Calling on the Senate Not to End the Current Development of Quality Standards for BiologicsThe Quality of Medical CareTHE HILL: Public Quality Standards for Biologic Drugs Promote Transparency and Competition; Don’t Get Rid of ThemBiosimilars: The Grand ExperimentACI Expert Prof. Fuhr Quoted in Genetic Engineering & Biotechnology NewsDr. Joseph Fuhr Discusses Biosimilar Competition and Trends
